Together, we are exploring new ways to treat cancer and improve health

One of the most exciting advances in cancer research is the idea that treatment can be very precise, based on the unique genetic information found in each of us. It’s called Precision Medicine and we are at the leading edge.

Instead of one-size-fits-all treatments, we treat individuals based on their unique characteristics.

Thanks to the mapping of the human genome, we can explore options for treating individuals with highly targeted and effective solutions. Considering factors such as health history, lifestyle and diet can dramatically improve outcomes for those with cancer.

Scientists at the University of Calgary are making advances into some of the leading causes of death from cancer.

Our research leverages the potential of precision medicine. Lung, brain, head and neck, blood and pediatric cancers are in our sights.

Together, we will create a future of health where cancer is beaten at every stage.

Research outcomes to benefit society

Fuel transformational change

$150 million

The power of cancer prevention

We are exploring new ways to halt cancer before it starts.

Prevention is our most powerful line of defense. It’s a line we make stronger every day at the University of Calgary.

Our researchers are studying lifestyle factors. Exercise can reduce the risk of some cancers, but how much and what kind works best? We are generating answers to these and other vital questions.

Lowering recurrence rates. Reducing side effects of treatment. Preventing cancer, full stop.

Together, we can discover the power of prevention.

Using exercise to stay ahead of cancer

Exercising 300 minutes per week can help prevent cancer. How do we know? It’s just one of the exciting discoveries resulting from our recent studies.

Researcher Christine Friedenreich studied postmenopausal women who did 300 minutes per week of moderate to vigorous exercise.

The results of her one-week clinical trial shows participants reduced the body fat associated with an increased risk of postmenopausal breast cancer.

Let’s run with it. Together, we can find new ways to leave cancer in the dust.

Highlighting our detection detectives

Speed saves when detecting cancer.

The sooner cancer is detected, the quicker treatment can begin, and early treatment has the best chance of success.

Some of our brightest minds are exploring the many ways cancer attacks the body. We are uncovering new factors to help us screen people so we can reveal cancer when it is easily treatable.

Every day, our researchers and clinicians make headway, discovering subtle clues. We’re making cases to beat cancer faster. The clock is ticking.

Shedding new light on cancer

University of Calgary Researcher Dr. Joseph Dort is part of a national surgical trial exploring an innovative way to solve a new problem.

Some 30 per cent of patients who receive oral surgery have their cancer recur. In the trial, surgeons are using “blue light” rather than traditional “white light.” The difference? With blue light, normal tissue generates fluorescence.

By clearly seeing the cancerous tissue that needs to be removed, and sparing damage to normal healthy tissue, we can reduce cancer recurrence.

Individual pathways to treatment

Cancer attacks every person individually, so we are developing ways to treat each individual person.

The more we know about how cancer acts, and how it impacts each patient, the more precise and effective treatment can be.

We’re generating breakthroughs. Genome sequencing is leading to personalized therapies. New tests are identifying faint chemical fingerprints left in the blood by tumours. Researchers are finding ways to kill cancer by giving it a virus.

With precision medicine we are prolonging lives and hitting the hard targets.

Offering hope to patients, now and in the future

Before a treatment is made available for public use, it first goes through rigorous testing to ensure its safety and effectiveness. This testing is also known as a clinical trial.

As director of the Tom Baker Cancer Centre's Clinical Trials Unit, Dr. Gwyn Bebb knows that clinical trials are the reason for improvements in cancer treatments.

More than 100 trials are underway at the Tom Baker Clinical Trials Unit. These studies are providing thousands of patients access to the latest treatment innovations, increasing knowledge and expertise to effectively treat millions of others.

Together, we will build a better future

Contact information

Barb Giba
Associate Vice President, Development
Cumming School of Medicine